181 related articles for article (PubMed ID: 38612518)
1.
Machado I; Claramunt-Alonso R; Lavernia J; Romero I; Barrios M; Safont MJ; Santonja N; Navarro L; López-Guerrero JA; Llombart-Bosch A
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612518
[TBL] [Abstract][Full Text] [Related]
2. GISTs with
Cao Z; Li J; Sun L; Xu Z; Ke Y; Shao B; Guo Y; Sun Y
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612101
[TBL] [Abstract][Full Text] [Related]
3. Tropomyosin-Related Kinase Fusions in Gastrointestinal Stromal Tumors.
Lee JH; Shin SJ; Choe EA; Kim J; Hyung WJ; Kim HS; Jung M; Beom SH; Kim TI; Ahn JB; Chung HC; Shin SJ
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681640
[TBL] [Abstract][Full Text] [Related]
4. Fluorescent In Situ Hybridization Must be Preferred to pan-TRK Immunohistochemistry to Diagnose NTRK3-rearranged Gastrointestinal Stromal Tumors (GIST).
Castillon M; Kammerer-Jacquet SF; Cariou M; Costa S; Conq G; Samaison L; Douet-Guilbert N; Marcorelles P; Doucet L; Uguen A
Appl Immunohistochem Mol Morphol; 2021 Sep; 29(8):626-634. PubMed ID: 33758144
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal stromal tumors with BRAF gene fusions. A report of two cases showing low or absent KIT expression resulting in diagnostic pitfalls.
Torrence D; Xie Z; Zhang L; Chi P; Antonescu CR
Genes Chromosomes Cancer; 2021 Dec; 60(12):789-795. PubMed ID: 34398495
[TBL] [Abstract][Full Text] [Related]
6. Transcriptome sequencing identifies ETV6-NTRK3 as a gene fusion involved in GIST.
Brenca M; Rossi S; Polano M; Gasparotto D; Zanatta L; Racanelli D; Valori L; Lamon S; Dei Tos AP; Maestro R
J Pathol; 2016 Mar; 238(4):543-9. PubMed ID: 26606880
[TBL] [Abstract][Full Text] [Related]
7. Pan-TRK Immunohistochemistry Is Highly Correlated With NTRK3 Gene Rearrangements in Salivary Gland Tumors.
Csanyi-Bastien M; Lanic MD; Beaussire L; Ferric S; François A; Meseure D; Jardin F; Wassef M; Ruminy P; Laé M
Am J Surg Pathol; 2021 Nov; 45(11):1487-1498. PubMed ID: 33899788
[TBL] [Abstract][Full Text] [Related]
8. FGFR2::TACC2 fusion as a novel KIT-independent mechanism of targeted therapy failure in a multidrug-resistant gastrointestinal stromal tumor.
Dermawan JK; Vanderbilt CM; Chang JC; Untch BR; Singer S; Chi P; Tap WD; Antonescu CR
Genes Chromosomes Cancer; 2022 Jul; 61(7):412-419. PubMed ID: 35170141
[TBL] [Abstract][Full Text] [Related]
9. Pan-tropomyosin receptor kinase immunoreactivity, ETV6-NTRK3 fusion subtypes, and RET rearrangement in salivary secretory carcinoma.
Yamamoto H; Nozaki Y; Sugii A; Taguchi K; Hongo T; Jiromaru R; Sato M; Nakano T; Hashimoto K; Fujiwara M; Oda Y
Hum Pathol; 2021 Mar; 109():37-44. PubMed ID: 33301751
[TBL] [Abstract][Full Text] [Related]
10. A novel fusion between CDC42BPB and ALK in a patient with quadruple wild-type gastrointestinal stromal tumor.
Huang W; Yuan W; Ren L; Xu C; Luo R; Zhou Y; Lu W; Hao Q; Xu M; Hou Y
Mol Genet Genomic Med; 2022 May; 10(5):e1881. PubMed ID: 35319816
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal tumors of the gastrointestinal tract with NTRK rearrangements: a clinicopathological, immunophenotypic, and molecular study of eight cases, emphasizing their distinction from gastrointestinal stromal tumor (GIST).
Atiq MA; Davis JL; Hornick JL; Dickson BC; Fletcher CDM; Fletcher JA; Folpe AL; Mariño-Enríquez A
Mod Pathol; 2021 Jan; 34(1):95-103. PubMed ID: 32669612
[TBL] [Abstract][Full Text] [Related]
12. Molecular and clinicopathological features of KIT/PDGFRA wild-type gastrointestinal stromal tumors.
Nishida T; Naito Y; Takahashi T; Saito T; Hisamori S; Manaka D; Ogawa K; Hirota S; Ichikawa H
Cancer Sci; 2024 Mar; 115(3):894-904. PubMed ID: 38178783
[TBL] [Abstract][Full Text] [Related]
13. Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.
Boikos SA; Pappo AS; Killian JK; LaQuaglia MP; Weldon CB; George S; Trent JC; von Mehren M; Wright JA; Schiffman JD; Raygada M; Pacak K; Meltzer PS; Miettinen MM; Stratakis C; Janeway KA; Helman LJ
JAMA Oncol; 2016 Jul; 2(7):922-8. PubMed ID: 27011036
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of pediatric gastrointestinal stromal tumors.
Agaram NP; Laquaglia MP; Ustun B; Guo T; Wong GC; Socci ND; Maki RG; DeMatteo RP; Besmer P; Antonescu CR
Clin Cancer Res; 2008 May; 14(10):3204-15. PubMed ID: 18483389
[TBL] [Abstract][Full Text] [Related]
15. Current research and treatment for gastrointestinal stromal tumors.
Lim KT; Tan KY
World J Gastroenterol; 2017 Jul; 23(27):4856-4866. PubMed ID: 28785140
[TBL] [Abstract][Full Text] [Related]
16. NTRK2 expression in gastrointestinal stromal tumors with a special emphasis on the clinicopathological and prognostic impacts.
Sasa K; Son R; Oguchi A; Ashizawa K; Hasegawa N; Kubota D; Suehara Y; Takagi T; Okubo T; Akaike K; Sugimoto K; Takahashi M; Sakamoto K; Hashimoto T; Mine S; Fukunaga T; Ishijima M; Hayashi T; Yao T; Murakawa Y; Saito T
Sci Rep; 2024 Jan; 14(1):768. PubMed ID: 38191907
[TBL] [Abstract][Full Text] [Related]
17. A CD117 and CD34 immunoreactive sarcoma masquerading as a gastrointestinal stromal tumor: diagnostic pitfalls of ancillary studies in sarcoma.
Riddle ND; Gonzalez RJ; Bridge JA; Antonia S; Bui MM
Cancer Control; 2011 Jul; 18(3):152-9. PubMed ID: 21666577
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with
Shen YY; Li XQ; Yang LX; Fang Y; Nie MM; He ZR; Hou YY; Cao H; Wang M; Shen KT
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):804-813. PubMed ID: 34530562
[No Abstract] [Full Text] [Related]
20. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.
Liegl B; Hornick JL; Corless CL; Fletcher CD
Am J Surg Pathol; 2009 Mar; 33(3):437-46. PubMed ID: 19011564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
